US Patent Family Members and Approved Drugs for China Patent: 100552023
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for China Patent: CN100552023
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| ⤷ Start Trial | 2023-10-17 | ranibizumab | Genentech, Inc. | LUCENTIS |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
